Chengda Pharmaceuticals Co (SZSE:301201) 3-Year EBITDA Growth Rate : -15.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Chengda Pharmaceuticals Co 3-Year EBITDA Growth Rate?

Chengda Pharmaceuticals Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.14.

During the past 12 months, Chengda Pharmaceuticals Co's average EBITDA Per Share Growth Rate was -2.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -15.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 10 years, the highest 3-Year average EBITDA Per Share Growth Rate of Chengda Pharmaceuticals Co was 66.60% per year. The lowest was -66.20% per year. And the median was 22.80% per year.

Competitive Comparison of Chengda Pharmaceuticals Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Chengda Pharmaceuticals Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengda Pharmaceuticals Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengda Pharmaceuticals Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Chengda Pharmaceuticals Co's 3-Year EBITDA Growth Rate falls into.

Chengda Pharmaceuticals Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Chengda Pharmaceuticals Co (SZSE:301201) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Chengda Pharmaceuticals Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Chengda Pharmaceuticals Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengda Pharmaceuticals Co (SZSE:301201) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengda Pharmaceuticals Co Ltd (SZSE:301201) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

36 Huanghe Road, Huimin Street, Jiashan County, Zhejiang Province, Jiaxing, CHN, 314100

Website

http://www.chengdapharm.com

Chengda Pharmaceuticals Co Ltd is engaged in the research and development, production and sales of L-carnitine series products. The company mainly produces raw materials, food additives, feed additives, antibiotics, anti-cancer, anti-virus and other series of pharmaceutical intermediates. The products are sold to more than 30 countries and regions.

Chengda Pharmaceuticals Co (SZSE:301201) Headlines

No Headlines